April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Effect of 0.6% AR-12286 on Aqueous Humor Dynamics in 6 Normotensive Monkey Eyes
Author Affiliations & Notes
  • R.-F. Wang
    Ophthalmology, Mount Sinai School of Medicine, New York, New York
  • J. B. Serle
    Ophthalmology, Mount Sinai School of Medicine, New York, New York
  • C. Kopczynski
    Research, Aerie Pharmaceuticals, Inc, Research Triangle Park, North Carolina
  • Footnotes
    Commercial Relationships  R.-F. Wang, Aerie Pharmaceuticals Inc, F; J.B. Serle, Aerie Pharmaceuticals Inc, F; C. Kopczynski, Aerie Pharmaceuticals, Inc, E.
  • Footnotes
    Support  NEI EY01867, an unrestricted grant from RPB, and in part by Aerie Pharmaceuticals Inc
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1465. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R.-F. Wang, J. B. Serle, C. Kopczynski; Effect of 0.6% AR-12286 on Aqueous Humor Dynamics in 6 Normotensive Monkey Eyes. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1465.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Topical administration of AR-12286, a selective inhibitor of rho kinase, reduces intraocular pressure (IOP) in rabbits and monkeys. The purpose of this study is to determine the mechanism by which AR-12286 reduces IOP in normotensive monkey eyes when applied topically.

Methods: : Six normotensive monkeys were used. Tonographic outflow facility (C) was measured prior to drug administration, and repeated 4 hours after administration of 30 µl of 0.6% AR-12286 to one eye and 30 µl vehicle to the contralateral control eye. Baseline aqueous humor flow rates (F) were measured hourly for 4 hours on day 1. The following day, 30 µl of 0.6% AR-12286 was topically applied to one eye, and 30 µl vehicle to the contralateral control eye, one hour before F measurement. F was measured at the same times as on the baseline day beginning 1 hour after dosing. The pupil size was measured with a pupil gauge (mm) under natural room light immediately before drug administration (0 hr), then hourly for 4 hrs after drug administration during the flow measurements.

Results: : 4 hrs after administering a single-dose of 0.6% AR-12286 to 6 normotensive monkey eyes, C was increased (p<0.05) 39% in drug-treated eyes compared to contralateral vehicle-treated eyes. IOP measured tonographically in treated eyes was reduced (p<0.05) 19% when compared with either baseline measurements or contralateral vehicle-treated eyes. For 4 hrs after a single-dose of 0.6% AR-12286, F was unchanged (p>0.60) when compared with either contralateral vehicle-treated eyes or baseline values. The pupil size increased (p<0.05) 5% to13% for at least 4 hrs after drug administration when compared to the baseline values of the same eye. No difference (p>0.30) in pupil size was observed when the drug treated eyes were compared to the vehicle-treated contralateral control eyes.

Keywords: outflow: trabecular meshwork • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×